Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2008

01.04.2008

Medium- and long-term survival after pacemaker implant: Improved survival with right ventricular outflow tract pacing

verfasst von: Gabriel Vanerio, Juan L. Vidal, Pablo Fernández Banizi, Daniel Banina Aguerre, Pablo Viana, Jorge Tejada

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Long-term prognosis after pacemaker implant depends on numerous variables, particularly structural heart disease. There is evidence that apical stimulation could favor the development of heart failure and, therefore, influence mortality. Other right ventricular pacing sites have been studied, for example the outflow tract, but no reports regarding long-term clinical outcome are available.

Objective

Compare all-cause mortality between two different sites of stimulation in the right ventricle.

Methods

We retrospectively analyzed 150 consecutive patients who underwent pacemaker implantation because of complete AV block (spontaneous or after AV node ablation), symptomatic second-degree AV block, and symptomatic atrial fibrillation with slow ventricular response. All patients were implanted at the same institution with the standard technique. Apical stimulation was performed with a passive or active fixation lead and outflow tract pacing with an active fixation lead. Data collection period began in July 1999 and ended on December 2004. All patients included were greater than 70% ventricular paced during pacemaker follow-up. Patients older than 85 years were excluded from the analysis. Age, pacemaker mode, sex, ejection fraction, diabetes, and structural cardiac disease were analyzed. Mean age was 72 ± 7 years (median 74 years, range 27–85 years), 101 (67%) were male, 56 had implanted a VVI PM, and 94 patients a DDD PM. Patients were divided into two groups: outflow tract (55 patients) and apical pacing (95 patients). Mean follow-up was 1,231 ± 642 days (median 1,158 days, range 9 to 2,694 days), which ended on July 2007. Total mortality was examined with the Kaplan–Meier method to construct overall survival curves. Multivariate Cox proportional hazards regression models were performed.

Results

All patients or relatives were contacted personally or by phone. There were no major statistical differences in patient background between the two groups. During follow-up, 18 patients (32%) died in the outflow tract group and 49 (51%) in the apical group (log-rank p = 0.02). Cox regression multivariate analysis showed that outflow tract pacing and a low left ventricular ejection fraction (<40%) were the only independent variables with significant correlation with survival (p = 0.006 and 0.003, respectively).

Conclusions

Outflow tract pacing appears to improve medium- and long-term survival. Prospective randomized trials with a greater amount of patients are necessary to confirm the findings of this study.
Literatur
1.
Zurück zum Zitat Bernstein, V., Rotem, C. E., & Peretz, D. I. (1971). Permanent pacemakers: 8-year follow-up study. Incidence and management of congestive cardiac failure and perforations. Annals of Internal Medicine, 74, 361–369.PubMed Bernstein, V., Rotem, C. E., & Peretz, D. I. (1971). Permanent pacemakers: 8-year follow-up study. Incidence and management of congestive cardiac failure and perforations. Annals of Internal Medicine, 74, 361–369.PubMed
2.
Zurück zum Zitat Hansen, J. F., & Meibom, J. (1974). The prognosis for patients with complete heart block treated with permanent pacemaker. Acta Medica Scandinavica, 195, 385–389.PubMedCrossRef Hansen, J. F., & Meibom, J. (1974). The prognosis for patients with complete heart block treated with permanent pacemaker. Acta Medica Scandinavica, 195, 385–389.PubMedCrossRef
4.
Zurück zum Zitat Alpert, M. A., Curtis, J. J., Sanfelippo, J. F., et al. (1987). Comparative survival following permanent ventricular and dual-chamber pacing for patients with chronic symptomatic sinus node dysfunction with and without congestive heart failure. American Heart Journal, 113, 958–965. DOI 10.1016/0002-8703(87)90057-3.PubMedCrossRef Alpert, M. A., Curtis, J. J., Sanfelippo, J. F., et al. (1987). Comparative survival following permanent ventricular and dual-chamber pacing for patients with chronic symptomatic sinus node dysfunction with and without congestive heart failure. American Heart Journal, 113, 958–965. DOI 10.​1016/​0002-8703(87)90057-3.PubMedCrossRef
5.
Zurück zum Zitat Rosenqvist, M., & Nordlander, R. (1992). Survival in patients with permanent pacemakers. Cardiology Clinics, 10, 691–703.PubMed Rosenqvist, M., & Nordlander, R. (1992). Survival in patients with permanent pacemakers. Cardiology Clinics, 10, 691–703.PubMed
6.
Zurück zum Zitat Bush, D. E., & Finucane, T. E. (1994). Permanent cardiac pacemakers in the elderly. Journal of the American Geriatrics Society, 42, 326–334.PubMed Bush, D. E., & Finucane, T. E. (1994). Permanent cardiac pacemakers in the elderly. Journal of the American Geriatrics Society, 42, 326–334.PubMed
8.
Zurück zum Zitat Lamas, G. A., Pashos, C. L., Normand, S. L., & McNeil, B. (1995). Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation, 91, 1063–1069.PubMed Lamas, G. A., Pashos, C. L., Normand, S. L., & McNeil, B. (1995). Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation, 91, 1063–1069.PubMed
9.
Zurück zum Zitat Brunner, M., Olschewski, M., Geibel, A., Bode, C., & Zehender, M. (2004). Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. European Heart Journal, 25, 88–95. DOI 10.1016/j.ehj.2003.10.022.PubMedCrossRef Brunner, M., Olschewski, M., Geibel, A., Bode, C., & Zehender, M. (2004). Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. European Heart Journal, 25, 88–95. DOI 10.​1016/​j.​ehj.​2003.​10.​022.PubMedCrossRef
10.
11.
Zurück zum Zitat Saxon, L. A., Stevenson, W. G., Middlekauff, H. R., & Stevenson, L. W. (1993). Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. American Heart Journal, 125, 1306–1310. DOI 10.1016/0002-8703(93)90999-P.PubMedCrossRef Saxon, L. A., Stevenson, W. G., Middlekauff, H. R., & Stevenson, L. W. (1993). Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. American Heart Journal, 125, 1306–1310. DOI 10.​1016/​0002-8703(93)90999-P.PubMedCrossRef
16.
Zurück zum Zitat Tse, H. F., Yu, C., Wong, K. K., et al. (2002). Functional abnormalities in patients with permanent right ventricular pacing: The effect of sites of electrical stimulation. Journal of the American College of Cardiology, 40, 1451–1458. DOI 10.1016/S0735-1097(02)02169-1.PubMedCrossRef Tse, H. F., Yu, C., Wong, K. K., et al. (2002). Functional abnormalities in patients with permanent right ventricular pacing: The effect of sites of electrical stimulation. Journal of the American College of Cardiology, 40, 1451–1458. DOI 10.​1016/​S0735-1097(02)02169-1.PubMedCrossRef
19.
Zurück zum Zitat Deharo, J. C. (2000). Left bundle branch block. Electrocardiographic and prognostic aspects. Archives des maladies du coeur et des vaisseaux, 93, 31–37.PubMed Deharo, J. C. (2000). Left bundle branch block. Electrocardiographic and prognostic aspects. Archives des maladies du coeur et des vaisseaux, 93, 31–37.PubMed
20.
Zurück zum Zitat McAnulty, J. H., Rahimtoola, S. H., Murphy, E. S., et al. (1978). Prospective study of sudden death in “high-risk” bundle-branch block. New England Journal of Medicine, 299, 209–215.PubMedCrossRef McAnulty, J. H., Rahimtoola, S. H., Murphy, E. S., et al. (1978). Prospective study of sudden death in “high-risk” bundle-branch block. New England Journal of Medicine, 299, 209–215.PubMedCrossRef
21.
Zurück zum Zitat Naslafkih, A., & Sestier, F. (2002). Mortality analysis in patients with atrial fibrillation and implantable permanent pacemaker after ablation of the atrioventricular node. Journal of Insurance Medicine, 34, 92–93.PubMed Naslafkih, A., & Sestier, F. (2002). Mortality analysis in patients with atrial fibrillation and implantable permanent pacemaker after ablation of the atrioventricular node. Journal of Insurance Medicine, 34, 92–93.PubMed
22.
Zurück zum Zitat Kay, G. N., Ellenbogen, K. A., Giudici, M., et al. (1998). The Ablate and Pace Trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. Journal of Interventional Cardiac Electrophysiology, 2, 121–135. DOI 10.1023/A:1009795330454.PubMedCrossRef Kay, G. N., Ellenbogen, K. A., Giudici, M., et al. (1998). The Ablate and Pace Trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. Journal of Interventional Cardiac Electrophysiology, 2, 121–135. DOI 10.​1023/​A:​1009795330454.PubMedCrossRef
23.
Zurück zum Zitat Twidale, N., Manda, V., Nave, K., & Seal, A. (1998). Predictors of outcome after radiofrequency catheter ablation of the atrioventricular node for atrial fibrillation and congestive heart failure. American Heart Journal, 136, 647–657. DOI 10.1016/S0002-8703(98)70012-2.PubMedCrossRef Twidale, N., Manda, V., Nave, K., & Seal, A. (1998). Predictors of outcome after radiofrequency catheter ablation of the atrioventricular node for atrial fibrillation and congestive heart failure. American Heart Journal, 136, 647–657. DOI 10.​1016/​S0002-8703(98)70012-2.PubMedCrossRef
24.
Zurück zum Zitat Twidale, N., Manda, V., Holliday, R., et al. (1999). Mitral regurgitation after atrioventricular node catheter ablation for atrial fibrillation and heart failure: Acute hemodynamic features. American Heart Journal, 138, 1166–1175. DOI 10.1016/S0002-8703(99)70084-0.PubMedCrossRef Twidale, N., Manda, V., Holliday, R., et al. (1999). Mitral regurgitation after atrioventricular node catheter ablation for atrial fibrillation and heart failure: Acute hemodynamic features. American Heart Journal, 138, 1166–1175. DOI 10.​1016/​S0002-8703(99)70084-0.PubMedCrossRef
25.
Zurück zum Zitat Vergara, G. (2001). Long-term survival after ablation of atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. Italian Heart Journal. Supplement, 2, 1243–1245. Vergara, G. (2001). Long-term survival after ablation of atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. Italian Heart Journal. Supplement, 2, 1243–1245.
26.
Zurück zum Zitat Ozcan, C., Jahangir, A., Friedman, P. A., et al. (2001). Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. New England Journal of Medicine, 344, 1043–1051. DOI 10.1056/NEJM200104053441403.PubMedCrossRef Ozcan, C., Jahangir, A., Friedman, P. A., et al. (2001). Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. New England Journal of Medicine, 344, 1043–1051. DOI 10.​1056/​NEJM200104053441​403.PubMedCrossRef
27.
Zurück zum Zitat Bourke, J. P., Hawkins, T., Keavey, P., et al. (2002). Evolution of ventricular function during permanent pacing from either right ventricular apex or outflow tract following AV-junctional ablation for atrial fibrillation. Europace, 4, 219–228. DOI 10.1053/eupc.2002.0238.PubMedCrossRef Bourke, J. P., Hawkins, T., Keavey, P., et al. (2002). Evolution of ventricular function during permanent pacing from either right ventricular apex or outflow tract following AV-junctional ablation for atrial fibrillation. Europace, 4, 219–228. DOI 10.​1053/​eupc.​2002.​0238.PubMedCrossRef
28.
Zurück zum Zitat Stambler, B. S., Ellenbogen, K., Zhang, X., et al. (2003). ROVA Investigators. Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. Journal of Cardiovascular Electrophysiology, 14, 1180–1186. DOI 10.1046/j.1540-8167.2003.03216.x.PubMedCrossRef Stambler, B. S., Ellenbogen, K., Zhang, X., et al. (2003). ROVA Investigators. Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. Journal of Cardiovascular Electrophysiology, 14, 1180–1186. DOI 10.​1046/​j.​1540-8167.​2003.​03216.​x.PubMedCrossRef
29.
Zurück zum Zitat Mera, F., DeLurgio, D. B., Patterson, R. E., Merlino, J. D., Wade, M. E., & Leon, A. R. (1999). A comparison of ventricular function during high right ventricular septal and apical pacing after his-bundle ablation for refractory atrial fibrillation. Pacing and Clinical Electrophysiology, 22, 1234–1239. DOI 10.1111/j.1540-8159.1999.tb00606.x.PubMedCrossRef Mera, F., DeLurgio, D. B., Patterson, R. E., Merlino, J. D., Wade, M. E., & Leon, A. R. (1999). A comparison of ventricular function during high right ventricular septal and apical pacing after his-bundle ablation for refractory atrial fibrillation. Pacing and Clinical Electrophysiology, 22, 1234–1239. DOI 10.​1111/​j.​1540-8159.​1999.​tb00606.​x.PubMedCrossRef
30.
Zurück zum Zitat Muto, C., Luca, O., Canciello, M., et al. (2007). Effect of pacing the right ventricular mid-septum tract in patients with permanent atrial fibrillation and low ejection fraction effect of pacing the RV mid-septum tract. Journal of Cardiovascular Electrophysiology, 18, 1032–1036. DOI 10.1111/j.1540-8167.2007.00914.x.PubMedCrossRef Muto, C., Luca, O., Canciello, M., et al. (2007). Effect of pacing the right ventricular mid-septum tract in patients with permanent atrial fibrillation and low ejection fraction effect of pacing the RV mid-septum tract. Journal of Cardiovascular Electrophysiology, 18, 1032–1036. DOI 10.​1111/​j.​1540-8167.​2007.​00914.​x.PubMedCrossRef
32.
Zurück zum Zitat McGavigan, A. D., Roberts-Thomson, K. C., Hillock, R. J., Stevenson, I. H., & Mond, H. G. (2006). Right ventricular outflow tract pacing: Radiographic and electrocardiographyc correlates of lead position. Pacing and Clinical Electrophysiology, 29, 1063–1068. DOI 10.1111/j.1540-8159.2006.00499.x.PubMedCrossRef McGavigan, A. D., Roberts-Thomson, K. C., Hillock, R. J., Stevenson, I. H., & Mond, H. G. (2006). Right ventricular outflow tract pacing: Radiographic and electrocardiographyc correlates of lead position. Pacing and Clinical Electrophysiology, 29, 1063–1068. DOI 10.​1111/​j.​1540-8159.​2006.​00499.​x.PubMedCrossRef
Metadaten
Titel
Medium- and long-term survival after pacemaker implant: Improved survival with right ventricular outflow tract pacing
verfasst von
Gabriel Vanerio
Juan L. Vidal
Pablo Fernández Banizi
Daniel Banina Aguerre
Pablo Viana
Jorge Tejada
Publikationsdatum
01.04.2008
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2008
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-008-9238-x

Weitere Artikel der Ausgabe 3/2008

Journal of Interventional Cardiac Electrophysiology 3/2008 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.